Cancers of the blood, bone marrow, and lymphatic system are collectively referred to as blood cancer. When the body's Red Blood Cell (RBC), White Blood Cell (WBC) or Platelet production is unusual or abnormal, blood cancer develops. It normally begins in the bone marrow, which is responsible for the production of blood. The normal functioning, growth, and development of blood cells that fight infection and make healthy blood cells are disrupted by this type of cancer. Broadly, this group of cancers includes- Lymphoma, Leukemia or Myeloma.
Since there are many myths related to blood cancer that float around, Dr Niti Raizada, Director - Medical Oncology and Hemato-Oncology, Fortis Hospitals, Bangalore debunks five common misconceptions about blood cancer.
Myth: A bone marrow transplant is required for all individuals with blood cancer.
Fact:Not all patients with blood cancer require a transplant. The need of a bone marrow transplant is evaluated individually based on their underlying diagnosis, treatment response, and tumor genetic profile. Patients' response to treatment in cases of acute leukemia has improved thanks to cutting-edge genetic profiling technologies combined with innovative tailored medication.
Myth: Leukemia and blood cancer are the same
Fact:There are three types of blood cancers- Leukemia, Lymphoma, and Myeloma. Leukemia is a type of cancer that affects all white blood cells and prevent them from performing their primary function of fighting infections and these abnormal cells are also found in blood. This is commonly seen in young children under the age of 15.
Lymphoma is a cancer of the lymphatic system and lymph nodes that mostly affects lymphocytes, a kind of white blood cell. It is typically diagnosed in people between the ages of 15 and 35, as well as those over 50.
Myeloma is cancer that affects the plasma cells, which is a type of white blood cell that produces antibodies to protect the body from infection. The immune system is weakened and prone to infections because of this cancer.